Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.


TSX:MBX - Post by User

Post by yielddudeon Nov 20, 2023 2:19pm
202 Views
Post# 35744859

My notes/thoughts on meeting

My notes/thoughts on meeting$15-$25M per year in royalties down the road (I assume CAD but not certain), I think I have heard $10-$15M USD in past cc's. This is U.S. market for catheter clearance. That increases with geographic expansion and other indications.

on the Q&A, someone gave figures to arrive at $95M usd present value at future royalties beginning in 5 years at the bottom of given range of estimates. Currie said yes, that's in the ballpark. That's more than 3x current market value for that one asset.

Someone asked about getting fast trac for approval. Cameron said it was possible (not probable), but if so, could shave 1 year off time to market (or approval time)

Currie mentioned that backlog today was at highest ever, entering 2024 with a good portion of revenue projections already in the form of orders.
<< Previous
Bullboard Posts
Next >>